Reaction Details Report a problem with these data
Target
Capsid protein
Ligand
BDBM50088372
Substrate
n/a
Meas. Tech.
ChEMBL_1743345 (CHEMBL4177855)
EC50
819±n/a nM
Citation
 Ren, Q; Liu, X; Luo, Z; Li, J; Wang, C; Goldmann, S; Zhang, J; Zhang, Y Discovery of hepatitis B virus capsid assembly inhibitors leading to a heteroaryldihydropyrimidine based clinical candidate (GLS4). Bioorg Med Chem 25:1042-1056 (2017) [PubMed]  Article 
Target
Name:
Capsid protein
Synonyms:
Core antigen
Type:
PROTEIN
Mol. Mass.:
26278.39
Organism:
Hepatitis B virus
Description:
ChEMBL_450484
Residue:
230
Sequence:
MIFVLGGCRHKLVCSPAPCNFFHLCLIISCSCPTVHASKLCLGWLWGMHIDPYKEFGASVELLSFLPSDFFPSIRDLLDTASALYREALESPEHCSPHHTALRQAILCWGELMNLATWVGSNLEDPASRELVVSYVNVNMGLKIRQLLWFHISCLTFGRETVLEYLVSFGVWIRTPPAYRPPNAPILSTLPETTVVRRRGRSPRRRTPSPRRRRSQSPRRRRSQSRESQC
  
Inhibitor
Name:
BDBM50088372
Synonyms:
CHEBI:63624 | NV-02B | Sebivo | Telbivudine | Tyzeka
Type:
Small organic molecule
Emp. Form.:
C10H14N2O5
Mol. Mass.:
242.2286
SMILES:
Cc1cn([C@@H]2C[C@@H](O)[C@H](CO)O2)c(=O)[nH]c1=O |r|
Structure:
Search PDB for entries with ligand similarity: